Clinical Trials Browser

OTHER × Interventional × tamibarotene × Clear all

NCT06983210 2025-08-14

GRAPE

Phase 2 Recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT05064618 2024-04-04

MIKE-1

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06085638 2024-03-07

Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic

NCT00985530 2013-10-30

Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute